Cite

HARVARD Citation

    Soglia, S. et al. (2022). Adalimumab for interleukin‐1β‐mediated chronic non‐scarring scalp folliculitis: Case report and literature review. Journal of dermatology. 49 (1), pp. 157-160. [Online]. 
  
Back to record